Clinical Trials Browser

OTHER_GOV × HER2 Positive Metastatic Breast Cancer × Capecitabine × Clear all

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer